Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

Clinical trial NCT01814800 · COMPLETED

Trial details

NCT number: NCT01814800
Sponsor: ADMA Biologics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency Disorder

Start date: 2014-02-01
Primary completion: 2014-12-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.